B2B health-tech start-up achieves platform stickiness

By Helen Adams
India’s SaaS platform, HealthPlix, adopts multi-channel strategy to empower doctors, hits 10k MAU

India's fastest growing SaaS platform for doctors has announced a new milestone of 10,000 monthly active users (MAU) with 70% of them being power users of the platform. 

HealthPlix Technologies, a B2B start-up, claims the pandemic fuelled its success through its multi-channel strategy and a dedication to supporting doctors with proprietary digital tools. 

Headquartered in Bangalore, India,  HealthPlix was founded in 2014. By 2021, HealthPlix had raised US$13.5mn, as part of its ongoing Series B funding round led by Lightspeed Ventures. 



HealthPlix Technologies creates an increase in patient foot fall

Over 2021, the number of new patients added and the corresponding prescriptions written by doctors through the platform have grown. The progress over the past year comes at a time when doctors in India have shown significant inclination towards digitization of healthcare practice - and many have turned to HealthPlix. 

The new strategy has led to:

  • An increased number of power users
  • Platform stickiness 
  • Doctor productivity – on an average 20% increase in patient foot fall

Power users are doctors who have shown a very high engagement rate with the HealthPlix platform with per doctor daily usage of 3+ hours. Since its inception, 1.6 crore unique patients have been treated through the HealthPlix platform by doctors practising in more than 15 specialities. 


Digitising healthcare in a doctor first company 

“With the new multi-channel strategy we are getting a step closer to the doctor  and engaging with them at multiple touch points”, said Sandeep Gudibanda, HealthPlix Technologies CEO. “Being a doctor first company, we have differentiated ourselves from other platforms by putting our doctor users at the centre of our growth strategy. We have served more than 1.2% of the patient population in India and stay committed to digitising healthcare for Bharat. Moving forward, HealthPlix is well-positioned to release 3-4 new products for doctors by early 2022.” 

As a part of its ongoing investments, HealthPlix will welcome 3-4 more products in 2022, to support doctors and ensure more positive health outcomes for healthcare patients. 

The company has received funding from leading investors such as:

  • Lightspeed Venture Partners
  • JSW Ventures
  • Kalaari Capital
  • Chiratae Ventures



Featured Articles

Healthcare Business roundup: Baxter, Sanofi & Eli Lilly

Baxter International to sell kidney care spin-off Vantive; Sanofi's consumer health unit ‘to be separated’; Eli Lilly to buy Morphic Holding for $3.2bn

Trane Technologies Helping US Hospitals Meet Climate Pledge

Christy Fetsch of Trane Technologies explains how the company is helping US hospitals meet White House sustainability pledges for US healthcare provision

Nestlé Health Science Targets Weight Loss Side-Effects

Nestlé Health Science launches nutrition initiative to counteract side effects of weight-loss drugs, including hollowed-out 'Ozempic Face'

Eli Lilly Alzheimer's Drug Kisunla Approved in US by FDA

Medical Devices & Pharma

WEF: Gender Health Gap 'Costs women 75mn years of Life'

Medical Devices & Pharma

Schneider: Swathe of NHS Failing to Measure Sustainability